BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 8950679)

  • 1. Loss of heterozygosity in tuberous sclerosis hamartomas.
    Sepp T; Yates JR; Green AJ
    J Med Genet; 1996 Nov; 33(11):962-4. PubMed ID: 8950679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tuberous sclerosis gene on chromosome 9q34 acts as a growth suppressor.
    Green AJ; Johnson PH; Yates JR
    Hum Mol Genet; 1994 Oct; 3(10):1833-4. PubMed ID: 7849709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions.
    Henske EP; Scheithauer BW; Short MP; Wollmann R; Nahmias J; Hornigold N; van Slegtenhorst M; Welsh CT; Kwiatkowski DJ
    Am J Hum Genet; 1996 Aug; 59(2):400-6. PubMed ID: 8755927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of heterozygosity in the tuberous sclerosis (TSC2) region of chromosome band 16p13 occurs in sporadic as well as TSC-associated renal angiomyolipomas.
    Henske EP; Neumann HP; Scheithauer BW; Herbst EW; Short MP; Kwiatkowski DJ
    Genes Chromosomes Cancer; 1995 Aug; 13(4):295-8. PubMed ID: 7547639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients.
    Green AJ; Smith M; Yates JR
    Nat Genet; 1994 Feb; 6(2):193-6. PubMed ID: 8162074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberous sclerosis-like lesions in epileptogenic human neocortex lack allelic loss at the TSC1 and TSC2 regions.
    Wolf HK; Normann S; Green AJ; von Bakel I; Blümcke I; Pietsch T; Wiestler OD; von Deimling A
    Acta Neuropathol; 1997 Jan; 93(1):93-6. PubMed ID: 9006662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biallelic TSC gene inactivation in tuberous sclerosis complex.
    Crino PB; Aronica E; Baltuch G; Nathanson KL
    Neurology; 2010 May; 74(21):1716-23. PubMed ID: 20498439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant tumors of the kidney, brain, and soft tissues in children and young adults with the tuberous sclerosis complex.
    Al-Saleem T; Wessner LL; Scheithauer BW; Patterson K; Roach ES; Dreyer SJ; Fujikawa K; Bjornsson J; Bernstein J; Henske EP
    Cancer; 1998 Nov; 83(10):2208-16. PubMed ID: 9827727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomas suggests different genetic mechanisms for pathogenesis of TSC lesions.
    Niida Y; Stemmer-Rachamimov AO; Logrip M; Tapon D; Perez R; Kwiatkowski DJ; Sims K; MacCollin M; Louis DN; Ramesh V
    Am J Hum Genet; 2001 Sep; 69(3):493-503. PubMed ID: 11468687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal angiomyolipoma (AML) harboring a missense mutation of
    Idogawa M; Hida T; Tanaka T; Ohira N; Tange S; Sasaki Y; Uhara H; Masumori N; Tokino T; Natori H
    Cancer Biol Ther; 2020 Apr; 21(4):315-319. PubMed ID: 31847710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 9q34 loss of heterozygosity in a tuberous sclerosis astrocytoma suggests a growth suppressor-like activity also for the TSC1 gene.
    Carbonara C; Longa L; Grosso E; Borrone C; Garrè MG; Brisigotti M; Migone N
    Hum Mol Genet; 1994 Oct; 3(10):1829-32. PubMed ID: 7849708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apparent preferential loss of heterozygosity at TSC2 over TSC1 chromosomal region in tuberous sclerosis hamartomas.
    Carbonara C; Longa L; Grosso E; Mazzucco G; Borrone C; Garrè ML; Brisigotti M; Filippi G; Scabar A; Giannotti A; Falzoni P; Monga G; Garini G; Gabrielli M; Riegler P; Danesino C; Ruggieri M; Magro G; Migone N
    Genes Chromosomes Cancer; 1996 Jan; 15(1):18-25. PubMed ID: 8824721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonality of tuberous sclerosis harmatomas shown by non-random X-chromosome inactivation.
    Green AJ; Sepp T; Yates JR
    Hum Genet; 1996 Feb; 97(2):240-3. PubMed ID: 8566961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that lymphangiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis.
    Smolarek TA; Wessner LL; McCormack FX; Mylet JC; Menon AG; Henske EP
    Am J Hum Genet; 1998 Apr; 62(4):810-5. PubMed ID: 9529362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole Exome Sequencing Identifies TSC1/TSC2 Biallelic Loss as the Primary and Sufficient Driver Event for Renal Angiomyolipoma Development.
    Giannikou K; Malinowska IA; Pugh TJ; Yan R; Tseng YY; Oh C; Kim J; Tyburczy ME; Chekaluk Y; Liu Y; Alesi N; Finlay GA; Wu CL; Signoretti S; Meyerson M; Getz G; Boehm JS; Henske EP; Kwiatkowski DJ
    PLoS Genet; 2016 Aug; 12(8):e1006242. PubMed ID: 27494029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization of tuberous sclerosis 2 mRNA and its protein product tuberin in normal human brain and in cerebral lesions of patients with tuberous sclerosis.
    Kerfoot C; Wienecke R; Menchine M; Emelin J; Maize JC; Welsh CT; Norman MG; DeClue JE; Vinters HV
    Brain Pathol; 1996 Oct; 6(4):367-75. PubMed ID: 8944308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of heterozygosity in the tuberous sclerosis gene associated regions in adenocarcinoma of the lung accompanied by multiple atypical adenomatous hyperplasia.
    Suzuki K; Ogura T; Yokose T; Nagai K; Mukai K; Kodama T; Nishiwaki Y; Esumi H
    Int J Cancer; 1998 Aug; 79(4):384-9. PubMed ID: 9699531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refined localization of TSC1 by combined analysis of 9q34 and 16p13 data in 14 tuberous sclerosis families.
    Janssen B; Sampson J; van der Est M; Deelen W; Verhoef S; Daniels I; Hesseling A; Brook-Carter P; Nellist M; Lindhout D
    Hum Genet; 1994 Oct; 94(4):437-40. PubMed ID: 7927344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs.
    Dabora SL; Jozwiak S; Franz DN; Roberts PS; Nieto A; Chung J; Choy YS; Reeve MP; Thiele E; Egelhoff JC; Kasprzyk-Obara J; Domanska-Pakiela D; Kwiatkowski DJ
    Am J Hum Genet; 2001 Jan; 68(1):64-80. PubMed ID: 11112665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-level mosaicism in tuberous sclerosis complex in four unrelated patients: Comparison of clinical characteristics and diagnostic pathways.
    Manzanilla-Romero HH; Weis D; Schnaiter S; Rudnik-Schöneborn S
    Am J Med Genet A; 2021 Dec; 185(12):3851-3858. PubMed ID: 34328706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.